首页> 美国卫生研究院文献>other >Alternative Reinforcer Response Cost Impacts Methamphetamine Choice in Humans
【2h】

Alternative Reinforcer Response Cost Impacts Methamphetamine Choice in Humans

机译:替代加强能力成本会影响人类的甲基苯丙胺选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Methamphetamine use disorders are a persistent public health concern. Behavioral treatments have demonstrated that providing access to non-drug alternative reinforcers reduces methamphetamine use. The purpose of this human laboratory experiment was to determine how changes in response cost for non-drug alternative reinforcers influenced methamphetamine choice. Seven subjects with past year histories of recreational stimulant use completed a placebo-controlled, crossover, double-blind protocol in which they first sampled doses of oral methamphetamine (0, 8 or 16 mg) and completed a battery of subject-rated and physiological measures. During subsequent sessions, subjects then made eight discrete choices between 1/8th of the sampled dose and an alternative reinforcer ($0.25). The response cost to earn a methamphetamine dose was always 500 responses (FR500). The response cost for the alternative reinforcer varied across sessions (FR500, FR1000, FR2000, FR3000). Methamphetamine functioned as a positive reinforcer and produced prototypical stimulant-like effects (e.g., elevated blood pressure, increased ratings of “Stimulated”). Choice for doses over money was sensitive to changes in response cost for alternative reinforcers in that more doses were taken at higher FR values than at lower FR values. Placebo choices changed as a function of alternative reinforcer response cost to a greater degree than active methamphetamine choices. These findings suggest that manipulating the effort necessary to earn alternative reinforcers could impact methamphetamine use.
机译:甲基苯丙胺使用障碍一直是公共健康问题。行为治疗已证明,提供使用非药物替代增强剂的途径可以减少甲基苯丙胺的使用。这项人类实验室实验的目的是确定非药物替代增强剂的响应成本变化如何影响甲基苯丙胺的选择。有过去一年的休闲娱乐刺激剂使用史的七名受试者完成了安慰剂对照,交叉,双盲方案,其中他们首先采样了口服甲基苯丙胺的剂量(0、8或16 mg),并完成了一系列受试者评定和生理测量。在随后的课程中,受试者随后在采样剂量的1/8 和替代补强剂(0.25美元)之间进行了八个离散选择。获得甲基苯丙胺剂量的响应成本始终为500响应(FR500)。替代增强剂的响应成本在各个会话期间有所不同(FR500,FR1000,FR2000,FR3000)。甲基苯丙胺起到积极的增强作用,并产生类似兴奋剂的原型作用(例如,血压升高,“刺激”等级增加)。选择剂量而不是金钱对替代增强剂的响应成本的变化很敏感,因为较高的FR值比较低的FR值要服用更多的剂量。安慰剂的选择作为替代补强剂反应成本的函数,其变化幅度要大于活性的甲基苯丙胺选择。这些发现表明,为获得替代增强剂而进行的必要努力可能会影响甲基苯丙胺的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号